OZEMPIC, VISION LOSS, AND LAWSUIT CLAIMS: WHAT DOES THE CURRENT EVIDENCE SAY?

Recently, there have been viral social media claims alleging that Ozempic (semaglutide) and other GLP-1 receptor agonist medications are causing irreversible vision loss due to a rare condition called NAION, and that thousands of lawsuits have been filed. As of August 2025, there is no confirmed scientific evidence or regulatory alert linking Ozempic or similar medications to widespread NAION or permanent blindness.

 Lawsuits related to these medications primarily reference other side effects.

The safety of GLP-1 medications continues to be monitored by global regulatory authorities, and any new risks will be communicated by these bodies. Patients experiencing any vision changes should consult their healthcare provider promptly.

FAQ

·      Q: Is Ozempic proven to cause irreversible blindness or NAION?

·      A: No. To date, there is no established scientific evidence confirming that Ozempic or GLP-1 agonists cause NAION or irreversible vision loss at a population level. Regulatory agencies have not issued specific warnings about this risk.

·      Q: Are there lawsuits against Ozempic for causing blindness?

·      A: While lawsuits have been filed regarding various side effects of GLP-1 drugs, claims specifically connecting them to NAION and widespread blindness are not substantiated in current legal or medical records.

·      Q: What should I do if I am worried about my medication?

·      A: Continue your prescribed treatment and do not stop medications without consulting your healthcare professional. If you experience any new or sudden vision changes, seek medical attention immediately.

·      Q: Should I trust medical advice from social media influencers?

·      A: For your safety, rely only on information from qualified healthcare providers, regulatory authorities, or reputable organisations when it comes to medication safety.